The INFORMS Analytics+ Conference showcased how companies are turning advanced analytics and AI into measurable operational results
Museums take this educational role seriously, and many institutions understand the need to sustain and broaden their appeal. “They used to be these big ivory towers of knowledge and history and thought and art,” said Hilary Knight, director of Change& in London and former director of digital at Tate. “Museums themselves are changing their role to be centers for discussion and encounter and to be much more participatory.”
'Ghost ships' are vessels that disappear from public tracking systems, their location manipulated or their digital record misleading. An estimated 65% of outbound tankers crossing the Strait of Hormuz operate in dark mode, reducing visibility and increasing supply chain uncertainty. Misinformation in vessel tracking can cause manufacturing delays, compliance risks and financial losses. Layered verification processes, combining AIS data with other sources and escalation triggers for handling uncertain shipments, can help mitigate risk.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
CATONSVILLE, MD, December 10, 2020 – New research from a team of scientists at four leading universities has shed new light on the effectiveness of social advertising in specific product categories to learn which product categories tend to benefit more from social advertising, and which may not.
CATONSVILLE, MD, December 10, 2020 – INFORMS, the leading international association for operations research and analytics professionals, announced ECS as a Certified Analytics Professional (CAP) Preferred Employer.
Weeks before states expect to receive their first shipments of Covid-19 vaccines, conflicting messages from the federal government have obscured exactly how many doses may arrive. Some governors, including New York’s Andrew Cuomo and California’s Gavin Newsom, have made splashy announcements about how much of Pfizer Inc. and BioNTech SE’s vaccines they expect should the U.S. Food and Drug Administration authorize them this month. Other states can’t provide a solid answer given how quickly estimates change.
Forget one-time holiday deals. “We’re seeing a different transformation in the retail market and e-commerce is taking off in ways that are unbelievable,” said Sheldon Jacobson, a professor of computer science at the University of Illinois. That means you will need to do more research for the best price. “It’s prudent for people to sign up for a variety of retailers online and have emails come because they’ll tell you when their sales are,” Jacobson said. This year mindful gifts that focus on self-care or that can be used at home are topping holiday lists.
Recent announcements by Pfizer and BioNTech SE, Moderna, and AstraZeneca on their coronavirus vaccines have been promising. With so many companies racing to develop a vaccine, there are certain to be additional announcements forthcoming, ideally with comparable or even better efficacy data, less stringent cold-chain storage requirements, and even less adverse side effects. Although there are many more hurdles to traverse, establishing the efficacy of a vaccine in less than one year is nothing short of remarkable.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine